213:
195:
56:
167:
21:
111:
87:
121:
176:
97:
271:
are where people discuss how to make content on
Knowledge the best that it can be. You can use this page to start a discussion with others about how to improve the "
328:
333:
308:
313:
338:
298:
318:
303:
323:
229:
140:
220:
200:
268:
40:
on 5 September 2022 and it now redirects there. For the contribution history and old versions of the merged article please see
134:
92:
67:
55:
73:
286:
228:
on
Knowledge. If you would like to participate, please visit the project page, where you can join
279:
33:
126:
292:
212:
194:
225:
37:
166:
272:
116:
110:
86:
138:. Please visit the project page for details or ask questions at
49:
15:
165:
41:
28:
264:
Start a discussion about improving the
Abirritant page
224:, a collaborative effort to improve the coverage of
8:
189:
81:
66:does not require a rating on Knowledge's
191:
83:
218:This redirect is within the scope of
132:This redirect is within the scope of
53:
7:
329:Redirect-Class pharmacology articles
334:NA-importance pharmacology articles
309:Redirect-Class dermatology articles
141:Knowledge talk:WikiProject Medicine
72:It is of interest to the following
314:NA-importance dermatology articles
238:Knowledge:WikiProject Pharmacology
14:
339:WikiProject Pharmacology articles
241:Template:WikiProject Pharmacology
299:Redirect-Class medicine articles
211:
193:
119:
109:
85:
54:
19:
319:Dermatology task force articles
304:NA-importance medicine articles
324:All WikiProject Medicine pages
174:This redirect is supported by
150:Knowledge:WikiProject Medicine
1:
232:and see a list of open tasks.
153:Template:WikiProject Medicine
355:
177:the Dermatology task force
206:
173:
104:
80:
221:WikiProject Pharmacology
170:
244:pharmacology articles
169:
135:WikiProject Medicine
26:The contents of the
281:Start a discussion
171:
68:content assessment
260:
259:
256:
255:
252:
251:
188:
187:
184:
183:
156:medicine articles
48:
47:
346:
284:
282:
246:
245:
242:
239:
236:
215:
208:
207:
197:
190:
158:
157:
154:
151:
148:
129:
124:
123:
122:
113:
106:
105:
100:
89:
82:
59:
58:
50:
31:
23:
22:
16:
354:
353:
349:
348:
347:
345:
344:
343:
289:
288:
287:
285:
280:
278:
277:
243:
240:
237:
234:
233:
155:
152:
149:
146:
145:
127:Medicine portal
125:
120:
118:
95:
27:
20:
12:
11:
5:
352:
350:
342:
341:
336:
331:
326:
321:
316:
311:
306:
301:
291:
290:
266:
265:
262:
261:
258:
257:
254:
253:
250:
249:
247:
230:the discussion
216:
204:
203:
198:
186:
185:
182:
181:
172:
162:
161:
159:
131:
130:
114:
102:
101:
90:
78:
77:
71:
60:
46:
45:
24:
13:
10:
9:
6:
4:
3:
2:
351:
340:
337:
335:
332:
330:
327:
325:
322:
320:
317:
315:
312:
310:
307:
305:
302:
300:
297:
296:
294:
283:
276:
274:
270:
263:
248:
231:
227:
223:
222:
217:
214:
210:
209:
205:
202:
199:
196:
192:
179:
178:
168:
164:
163:
160:
143:
142:
137:
136:
128:
117:
115:
112:
108:
107:
103:
99:
94:
91:
88:
84:
79:
75:
69:
65:
61:
57:
52:
51:
43:
39:
35:
30:
25:
18:
17:
267:
235:Pharmacology
226:Pharmacology
219:
201:Pharmacology
175:
139:
133:
74:WikiProjects
63:
38:Antipruritic
98:Dermatology
42:its history
293:Categories
273:Abirritant
269:Talk pages
32:page were
29:Abirritant
275:" page.
147:Medicine
93:Medicine
64:redirect
70:scale.
34:merged
62:This
36:into
295::
96::
180:.
144:.
76::
44:.
Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.
